Many steps of peripheral glia development appear to be regulated by neuregulin1 (NRG1) signaling but the exact roles of the different NRG1 isoforms in these processes remain to be determined. While glial growth factor 2 (GGF2), a NRG1 type II isoform, is able to induce a satellite glial fate in neural crest stem cells, targeted mutations in mice have revealed a prominent role of NRG1 type III isoforms in supporting survival of Schwann cells at early developmental stages. Here, we investigated the role of NRG1 isoforms in the differentiation of Schwann cells from neural crest-derived progenitor cells. In multipotent cells isolated from dorsal root ganglia, soluble NRG1 isoforms do not promote Schwann cell features, whereas signaling by membrane-associated NRG1 type III induces the expression of the Schwann cell markers Oct-6/SCIP and S100 in neighboring cells, independent of survival. Thus, axon-bound NRG1 might actively promote both Schwann cell survival and differentiation. © 2002 Elsevier Science (USA)
INTRODUCTION
The neuregulins (NRGs) are a family of structurally related glycoproteins with many functions in the developing nervous system (reviewed in Adlkofer and Lai, 2000; Lemke, 2001) . NRG1, the best characterized of the four known NRG genes, encodes various isoforms that differ substantially in overall structure. NRG1 isoforms were originally named on the basis of distinct biological assays used for their identification and have later been classified in three major groups (Burden and Yarden, 1997) : NRG1 type I (neu differentiation factor, NDF; heregulin; acetylcholine receptor inducing activity, ARIA) is prominently expressed early in development of nonneural tissue (Falls et al., 1993; Holmes et al., 1992; Wen et al., 1992) ; NRG1 type II (glial growth factor, GGF) is expressed mainly in the nervous system (Marchionni et al., 1993) ; and NRG1 type III [sensory and motor neuron-derived factor, SMDF; cystein-rich domain (CRD)-NRG1] is the major isoform expressed by peripheral sensory and motor neurons, and is also produced in the brain (Bermingham-McDonogh et al., 1997; Ho et al., 1995; Yang et al., 1998) . The common feature of these NRG1 isoforms is an EGF-like domain that is required for receptor binding and on its own is sufficient to elicit ErbB receptor-mediated activation of downstream signaling pathways (Holmes et al., 1992) . While NRG1 types I and II share an immunoglobulin domain as part of their extracellular portion, the principal form of NRG1 type III contains a unique N-terminally located hydrophobic domain that mediates membrane insertion with the EGF homology domain exposed to the extracellular compartment (Schroering and Carey, 1998; Wang et al., 2001) .
Roles for NRG1 signaling in neural development have been analyzed in mice carrying selective mutations of NRG1 ectodomains. Mice homozygous for NRG1 lacking the EGF-like domain common to all isoforms display cardiac malformation and die around embryonic day 10.5 (E10.5) (Meyer and Birchmeier, 1995) . Besides considerable loss of neuronal cell populations, they exhibit severely
FIG. 1.
A 24-h survival assay with Schwann cell precursors. Sciatic nerves isolated from rat E14.5 embryos were dissociated and the cells were fixed at 3 or 24 h after culturing in the presence of soluble NRG1 type II (NRG1-II) or type III (NRG1-III). Immunostaining for p75 using a fluorescent Cy3-coupled secondary antibody revealed that the cultures mainly consisted of Schwann cell precursor cells. Shown are representative fields of Schwann cell precursor cultures 3 (A, B) and 24 h (C-H) after plating. Phase-contrast (B, D, F, and H). Magnification, ϫ20. (I) Cells that were immunoreactive to p75 antibody and that showed an intact nucleus (defined by means of DAPI staining) were considered for counting in order to determine relative survival rate. Total numbers of cells per coverslip of 24-h cultures were compared with the total number of p75-positive cells plated (3-h cultures, approx. 200 cells/coverslip). For each condition, three independent experiments were performed in triplicate. Relative survival rate of Schwann cell precursors is given in percentage Ϯ SD.
reduced numbers of presumptive glial cells in cranial ganglia and of Schwann cell precursors along peripheral nerves. Homozygous deletion of the exon encoding the immunoglobulin domain results in the specific loss of NRG1 type I and type II isoforms without affecting expression of NRG1 type III. Mice carrying this mutation also die around E10.5 with similar heart defects to those described above; however, early development of the peripheral glial lineage is not affected (Kramer et al., 1996; Meyer et al., 1997) . Furthermore, the nerves of NRG1 type III-deficient mice are initially populated by Schwann cell precursors, but are devoid of Schwann cells later in development (Wolpowitz et al., 2000) . The culmination of these genetic data indicate that NRG1 type III is required for Schwann cell development. However, it is unclear from these findings whether NRG1 type III is solely required to support survival of developing Schwann cells along the axons or whether NRG1 type III can also act as a differentiation cue that promotes maturation of Schwann cell precursors into early Schwann cells.
In vitro studies might allow discrimination between the specific roles of NRG1 in migration, survival, and differentiation of neural crest derivatives. With respect to early Schwann cell development, variants of NRG1 type I were shown to promote survival and maturation of cultured Schwann cell precursors isolated from peripheral nerves (Dong et al., 1995; Dong et al., 1999; Brennan et al., 2000) . A role for NRG1 in glial differentiation has also been shown in cultures of multipotent neural crest stem cells and neural crest derivatives that are instructed by NRG1 type II to choose a glial fate (Hagedorn et al., 1999; Shah et al., 1994) . However, NRG1 type II-treated cells differentiate into satellite glia expressing the transcription factor Erm and not into Schwann cells of the peripheral nerve that express the transcription factor Oct-6 (Hagedorn et al., 2000) . Based on the expression and genetic data, Schwann cell development in vivo might rather be regulated by NRG1 type III. Therefore, we here elucidated the potential functions of NRG1 type III in the Schwann cell lineage, using culture systems in which survival and differentiation can be investigated separately and independently of migration.
MATERIALS AND METHODS

Cell Cultures
Time-mated OFA rats were obtained from RCC Ltd. (Fü llinsdorf, Switzerland) .
Schwann cell precursor cultures. Cultures of rat Schwann cell precursors were prepared essentially as described by Lobsiger et al. (2000) . Briefly, sciatic nerves were dissected from rat E14.5 embryos and dissociated by incubation for 60 min at 37°C in 0.2% collagenase type IV (Worthington Biochemical Corp.), 0.12% hyaluronidase type IV-S (Sigma), and 0.03% trypsin inhibitor (Sigma). Cells were plated onto poly-L-lysine (Sigma)-, laminin (Sigma)-coated 15-mm glass coverslips (Arnold Bott AG) and cultured in defined medium with or without additional growth factors that were given to the medium 3 h after plating. Defined culture medium was used as previously described by Dong et al. (1995) . For the Schwann cell precursor survival assay, cells were plated at low density (approx. 200 cells/coverslip) and cultured in defined medium supplemented with soluble forms of either recombinant human NRG1 type III (also referred to as SMDF; R&D Systems) or recombinant human NRG1 type II (also referred to as rhGGF2; a gift from M. A. Marchionni, Cambridge NeuroScience), for 24 h prior to fixation with 3.7% paraformaldehyde in PBS. Long-term survival and differentiation were tested by plating the cells at high density and by extending the survival assay described above to 5 days. All assays were performed in triplicate.
DRG cell cultures. Cultures of rat DRG cells were prepared exactly as described by Hagedorn et al. (2000) . DRG were dissected from rat E15 embryos and dissociated by incubation in 0.25% trypsin (GIBCO/BRL), 0.03% collagenase type I (Worthington Biochemical) for 20 min at 37°C. Cells were plated at approximately 10.000 -20.000 cells per 35-mm culture dish (Corning) coated with poly-D-lysine (Roche Diagnostics) and fibronectin (Roche Diagnostics). DRG cultures were maintained in standard culture medium (Hagedorn et al., 1999; Stemple and Anderson, 1992) . Four hours after plating, the medium of some culture dishes was supplemented with either soluble NRG1 type III (SMDF; R&D Systems), soluble NRG1 type II (rhGGF2; Cambridge NeuroScience), or forskolin (Sigma). Cells were cultured for 4 days prior to fixation with 3.7% formaldehyde in PBS.
Construction of Retroviral Vectors
Vector construction was performed by using standard molecular cloning techniques. mycNRG1-III retrovirus. A NRG1 type III cDNA (SMDF; a gift from D. J. Carey, Penn State College of Medicine) was cloned in-frame into a retroviral vector called pBabeMT.APPuro. The vector has a myc-epitope tag upstream of the cloning site and is described in detail by Lo et al. (1997) . The plasmid contains an internal ribosomal entry site (IRES)-human placental alkaline phosphatase cassette downstream of the cloning site.
NRG1-III retrovirus. The NRG1 type III cDNA described above was cloned in-frame into a retroviral vector called pBabe.APPuro. The vector corresponds to pBabeMT.APPuro lacking the myc-epitope tag.
FIG. 2.
Long-term survival of Schwann cell precursors in the presence of NRG1 type II and III, and differentiation into early Schwann cells. Dissociated rat E14.5 nerves were plated and cultured over a period of 5 days in medium supplemented with soluble forms of NRG1 type II or type III (1 nM each). Fixed cells were immunolabeled by using anti-p75 and anti-S100 antibody visualized by FITC-conjugated and Cy-3-conjugated secondary antibody, respectively (A, C, E, and G). Differentiation of Schwann cell precursor cells (A, B, 3-h cultures) into early Schwann cells (E-H, 5-day cultures) is marked by the upregulation of S100 expression. In the absence of any survival cue, virtually all cells died within 5 days (C, D). (I) Percentage of cells (ϮSD) that were found to be double-positive for the expression of p75 and S100 was determined in four independent experiments. Between 100 and 150 p75-positive cells were scored per experiment. Note that many of the p75-positive cells do not express S100 (arrow). Phase-contrast (B, D, F, and H). Magnification, ϫ20.
Control retrovirus.
A GFP cDNA (pGreen Lantern, GIBCO/ Life Technologies) was cloned into a reengineered form of the retroviral vector pBabe.APPuro. The vector was modified by introducing GFP cDNA downstream of a tag that consisted of a nuclear localization signal (NLS) fused in-frame to the myc-epitope.
Viral supernatants for infection of DRG cell cultures were produced by transient transfection in Phoenix cells as described (http://www.uib.no/mbi/nolan/nl-phoenix.html).
Retroviral Infection of DRG Cells
Approximately 250,000 freshly isolated rat E15 DRG cells were plated on a fibronectin (Roche Diagnostics) substrate in a 35-mm dish (Corning). Cell cultures were maintained in standard culture medium (SM) for 3.5 h and then flushed four to five times with ice-cold PBS in order to remove most of the sensory neurons present in the culture. Cells were removed from culture dishes with 0.25% trypsin (GIBCO/BRL) for 2 min and replated at a density of 10.000 -20.000 cells per 35-mm culture dish coated with poly-D-lysine (Roche Diagnostics) and fibronectin (Roche Diagnostics). NRG1-III-and mycNRG1-III-expressing as well as control retroviral supernatants were diluted 1:4 with SM and added to the cells. After a 3-h incubation at 37°C, the viral solution was removed and the culture was allowed to recover in fresh SM for 1 h. The infection procedure was repeated once. Following infection, incubation continued in fresh SM. After 4 days of culture, cells were fixed in 3.7% formaldehyde in PBS and stained for the desired epitopes.
Immunocytochemistry
Cells were fixed in PBS containing 3.7% formaldehyde for 10 min at RT. Labeling of the cell surface antigen p75/LNGFR was performed in 10% goat serum, 0.1% BSA in PBS using a polyclonal rabbit anti-mouse p75 antibody (1:300 dilution; Chemicon) visualized by either FITC-conjugated donkey anti-rabbit IgG (1:200 dilution; Jackson ImmunoResearch Laboratories) or Cy3-coupled goat anti-rabbit IgG (1:500 dilution; Jackson ImmunoResearch Laboratories). To label intracellular antigens, cells were permeabilized for 20 min at RT by using 10% goat serum, 0.3% Triton X-100, 0.1% BSA in PBS. To reveal expression of S100, labeling (rabbit anti-cow S100; DAKO; 1:400 dilution) was performed for 1 h at RT and visualized by either Cy3 or FITC fluorescence. Rabbit anti-Oct-6/SCIP antibody (a gift from D. Meijer, Erasmus University, Rotterdam, The Netherlands) was used at a 1:200 dilution and visualized with FITC fluorescence. To visualize mycepitope tagged proteins, mouse monoclonal anti-human c-Myc antibody (9E10; 1:3 dilution; Developmental Studies Hybridoma Bank) was applied for 1 h at RT, followed by staining with Cy3-conjugated (1:300 dilution; Jackson ImmunoResearch Laboratories) goat anti-mouse IgG. AP labeling was performed with monoclonal anti-human alkaline phosphatase antibody (placental, clone 8B6; 1:300 dilution; Sigma) followed by incubation with Cy3-coupled IgG. Nuclei of the cells were visualized with DAPI (1 g/ml), a chromosome-specific fluorescent dye. Stained fixed cultures were embedded in AF1/Citifluor (Chemical Laboratory).
RESULTS
NRG1 Type III Rescues Schwann Cell Precursors in a 24-h Survival Assay
In order to address the cellular role of the NRG1 type III isoform in early stages of Schwann cell development, we exposed Schwann cell precursor cells to a soluble form of NRG1 type III. Schwann cell precursors were freshly isolated from embryonic rat sciatic nerves at E14.5 and cultured in defined medium, as described previously (Dong et al., 1995; Jessen et al., 1994; Lobsiger et al., 2000) . In a first experiment, a standard 24-h survival assay was performed (Jessen et al., 1994) . Approximately 200 cells were plated per 15-mm coverslip, and the medium was supplemented with different concentrations of NRG1 type III. In parallel, cells on sister coverslips were exposed to a soluble NRG1 type II isoform (GGF2) (Marchionni et al., 1993) that has been shown to have a gliogenic effect on neural crest cells (Shah et al., 1994) . The survival of Schwann cell precursors was assessed by comparing the number of viable p75-positive cells after 24 h to the number of p75-positive cells plated (Jessen et al., 1994) (Fig. 1) . Virtually no cells expressing the precursor marker p75 were found 24 h after plating when cultured in defined medium alone (Figs. 1C and 1D ). In contrast, when the medium was supplemented with NRG1 type II or type III, a significant number of p75-positive cells survived (Figs. 1E-1H ). Survival in the presence of 1 nM NRG1 type II was close to 100%, while in the presence of 1 nM or more NRG1 type III, maximal survival was 60% (Fig. 1I) . Thus, similar to NRG1 type I isoforms (Dong et al., 1995) , both type II and type III isoforms of NRG1 prevented death of Schwann cell precursors, albeit at different efficiencies.
Assessing Maturation of Schwann Cell Precursors in the Presence of Soluble NRG1 Type III
Previously, it has been shown that long-term survival of Schwann cell precursors promoted by NRG1 type I isoforms was accompanied by differentiation of the precursors to early Schwann cells (Dong et al., 1995 (Dong et al., , 1999 . Therefore, we addressed whether other NRG1 isoforms also support longterm survival and maturation of Schwann cell precursors. not induce expression of the Schwann cell-specific marker Oct-6 in neural crest-derived multipotent progenitor cells. Dorsal root ganglia isolated from rat E15 embryos were dissociated and the cells were plated at high density. Cultures were challenged with soluble forms of NRG1 type II or type III (1 nM each) over a period of 4 days. Fixed cells were labeled immunocytochemically for Oct-6. Staining was visualized with FITC-coupled secondary antibody. Schwann cell differentiation, as monitored by the expression of Oct-6, is induced by supplying the culture medium with forskolin (C, D). Addition of NRG1 type II or type III to the medium had no effect on Oct-6 expression (E, F) when compared with untreated sister plates (A, B). Phase-contrast (B, D, F, and H). Magnification, ϫ20.
Precursor cells were plated at high density in defined medium and treated with soluble forms of either NRG1 type II or type III over a period of 5 days. Differentiation into early Schwann cells was monitored by the upregulation of S100. In the presence of NRG1 type II, little cell death was observed as monitored by DAPI-staining of fragmented nuclei (data not shown). Moreover, 61 Ϯ 9% of the NRG1 type II-treated p75-positive cells displayed increased S100 immunoreactivity when compared with precursors on sister plates that were fixed 3 h after plating . In medium supplied with NRG1 type III, many cells showed fragmented nuclei (data not shown), but a substantial proportion of the cells survived in these conditions (Figs. 2G and 2H ). While virtually all of the surviving cells were p75-immunoreactive, 54 Ϯ 14% of these cells also expressed S100 (Figs. 2G and 2I) . Thus, many NRG1 type IIand type III-treated cells survived without differentiation, suggesting that the transition from Schwann cell precursors to early Schwann cells is not a cell-autonomous process that unfolds in cells prevented from undergoing apoptotic death Brennan et al., 2000) . Rather, it is likely that both survival and differentiation have to be actively promoted by extracellular cues.
Membrane-Bound but Not Soluble NRG1 Type III Promotes Schwann Cell Differentiation from DRG-Derived Multipotent Progenitor Cells
To identify signals that promote Schwann cell differentiation independent of survival, we employed a culture system of neural crest-derived cells in which cell death is minimal. Nonneuronal neural crest-derived cells isolated from early dorsal root ganglia (DRG) are multipotent, giving rise to neurons, satellite glia, and Schwann cells, as well as to nonneural cells, depending on the environmental conditions (Hagedorn et al., 1999 (Hagedorn et al., , 2000 . Moreover, although the survival of at least a subpopulation of these cells is supported by NRG1 signaling (Paratore et al., 2001) , we have established conditions in which more than 95% of progenitor cells isolated from embryonic rat DRG survive in the absence of exogenously added NRG1 (Hagedorn et al., 1999) . In agreement with previous studies (Hagedorn et al., 2000; Zorick and Lemke, 1996) , such progenitor cells derived from rat E15 DRG only occasionally adopted Schwann cell features while most of the cells displayed no or only weak expression of Schwann cell markers when cultured in standard medium (Figs. 3A and 3B) . However, these cells were competent to generate Schwann cells upon treatment for 4 days with forskolin, which elevates intracellular cAMP. Schwann cell differentiation was monitored by increased expression of the transcription factor Oct-6 (also called SCIP or Tst-1; He et al., 1989; Meijer et al., 1990; Monuki et al., 1989) (Figs. 3C and 3D ) and S100 (not shown). The NRG1 type II isoform GGF2 has been shown to regulate satellite gliogenesis in DRG-derived progenitor cells but did not induce expression of the Schwann cell marker Oct-6 (Figs. 3E and 3F; Hagedorn et al., 2000) . Likewise, addition of soluble NRG1 type III (1 nM) had no effect on Oct-6 levels and did not induce S100 expression (Figs. 3G and 3H; and data not shown). Moreover, Schwann cell differentiation of DRG-derived progenitor cells was not observed even when using concentrations of NRG1 type III (10 nM) 10-fold above saturation for survival and differentiation of sciatic nerve-derived Schwann cell precursors (data not shown).
Hydrophobic amino acids in the N-terminal domain of NRG1 type III confer membrane association (Schroering and Carey, 1998; Wang et al., 2001 ). Thus, the activity of NRG1 type III might depend on whether the factor is presented to cells as soluble or membrane-bound form. To address this issue, we sought to overexpress the factor in cultured cells to allow local NRG1 signaling to neighboring cells. Retroviral expression vectors were generated encoding (1) the NRG1 type III isoform carrying a human mycepitope tag; (2) NRG1 type III without a myc-epitope tag; and (3) an inert protein (nuclear green fluorescence protein, GFP) fused to a myc-epitope tag, serving as control (Fig. 4) . As a further marker of infected cells, all three vectors encoded alkaline phosphatase (AP) driven from an IRES. Immunostaining using an antibody to the myc-epitope tag was consistent with cell surface localization of NRG1 type III in infected postmigratory neural crest cells (Fig. 5 ), in agreement with previous reports that biochemically demonstrated membrane association of NRG1 type III upon cellular expression (Schroering and Carey, 1998; Wang et al., 2001) .
To address the role of cell surface-associated NRG1 type III in Schwann cell differentiation of multipotent progenitor cells, nonneuronal cells were isolated from DRG (see Materials and Methods) and plated at high density to allow short range cell-cell interactions. The undifferentiated cells were infected 3 h after plating either with retroviral vector-encoding NRG1 type III fused to a myc-epitope tag (mycNRG1-III) or with control retroviral vector (Fig. 4) .
FIG. 4.
Retroviral expression constructs encoding membranebound NRG1 type III. cDNAs encoding myc-tagged NRG1 type III (mycNRG1-III) or NRG1 type III without epitope tag (NRG1-III) were inserted into retroviral expression constructs. Control infections were performed by using a virus encoding a GFP fusion protein with a myc-epitope tag and a nuclear localization signal (NLS). Infected cells can be revealed by immunocytochemical detection of the myc-epitope tag or alkaline phosphatase (AP). LTR, long terminal repeats.
Four days postinfection, the cells were fixed and immunostained with antibodies against the myc-epitope tag and S100. In none of the infected cultures did we observe a general, wide-spread upregulation of Schwann cell markers as seen upon addition of forskolin (Fig. 3) . However, many NRG1 type III-expressing cells were associated with cells expressing high levels of S100 (Figs. 5C and 5D ). Intriguingly, processes of NRG1-expressing cells were often found in close contact to S100-positive cells (arrow in Fig. 5C ). In addition, cells in close proximity to NRG1 type IIIexpressing cells also expressed Oct-6 (Figs. 5G and 5H). As with S100-expressing cells, a striking correlation between Oct-6 labeling and cellular association with processes of NRG1 type III-positive cells was seen (arrow in Fig. 5G ). By contrast, control-infected cells were mostly not associated with S100-or Oct-6-positive cells (Figs. 5A , 5B, 5E, and 5F). Expression of Oct-6 in some cells of control cultures might have been due to cellular association with neurites of residual neurons possibly present in the cultures. However, staining for neurofilament only revealed very few neurons both in control and in mycNRG1-III-infected cultures, so that neuronal contact could not account for induction of Oct-6 expression in adjacent cells (data not shown). While the presence of few Oct-6-positive cells in control cultures might thus reflect a possible heterogeneity in the cultures, the strong association of Oct-6-expressing cells with mycNRG1-III-infected cells indicates that direct cell-cell contact resulted in NRG1 type III-mediated induction of the Schwann cell markers.
To exclude an involvement of membrane-associated myc-epitope tag in Schwann cell differentiation, neural crest-derived progenitor cells were infected with a retrovirus encoding NRG1 type III without epitope tag (Fig. 4) . Expression from the retroviral construct was monitored by staining for AP. Similar to epitope-tagged NRG1, the untagged form was also able to induce expression of both S100 and Oct-6 in neighboring cells, confirming the specificity of NRG type III in inducing a Schwann cell phenotype (Fig. 6) .
To quantify NRG1 type III-induced upregulation of Schwann cell markers, we counted cohorts of infected cells that displayed Schwann cell marker expression in their vicinity (Fig. 7) . Thereby, association of Schwann cells with infected cells was scored when at least one Oct-6-or one S100-positive cell was found in direct contact with an infected cell, and only cells strongly expressing S100 or Oct-6 (as e.g., shown in Figs. 5C and 5G) were taken into account. This conservative method represents the most sensitive way to measure a Schwann cell-inducing activity. Using these criteria, 30 Ϯ 10% of the control-infected cells were associated with S100-positive cells. In contrast, 71 Ϯ 5% of the NRG1 type III-expressing cells were found in close proximity to S100-positive Schwann cells. Likewise, Oct-6 staining was detectable adjacent to 71 Ϯ 7% of the NRG1 type III-expressing cells, while this number amounted to only 26 Ϯ 5% in the control-infected cultures. Similar numbers were obtained when Schwann cell differentiation was monitored in the vicinity of cells expressing untagged NRG1 (data not shown). The finding that even in control cultures some infected cells were found in proximity with a Schwann cell is likely due to random association of infected cells with single Schwann cells occasionally present in the culture independently of NRG1-expressing cells. To confirm the specificity of NRG1-dependent induction of Schwann cell traits, we performed two independent experiments in which association of Schwann cells was only counted when at least four cells were found in close vicinity to an infected cell (as e.g., represented in Fig. 5G ). Using these stringent criteria, 55-61.5% of cells expressing membrane-bound NRG1 were surrounded by Oct-6-expressing Schwann cells (Table 1 ). In contrast, we never observed control-infected cells to be associated with four or more Schwann cells (Table 1) . Thus, a highly significant relationship between cells expressing NRG1 and cells marked by S100 or Oct-6 was established by using different criteria of quantification ( Fig. 7; and Table 1 ), revealing a specific role for membrane-bound NRG1 type III in promoting Schwann cell differentiation.
DISCUSSION
The loss of Schwann cell precursors in mice deficient in components of the NRG1 signal transduction pathway precludes the analysis of a direct involvement of NRG1 in Schwann cell differentiation (Meyer et al., 1997; Morris et al., 1999; Riethmacher et al., 1997; Woldeyesus et al., 1999; Wolpowitz et al., 2000) . Appropriate culture systems turn out to be valuable tools to address this issue. Although NRG1 promotes survival and differentiation of Schwann cell precursors isolated from peripheral nerves (Dong et al., 1995 (Dong et al., , 1999 Brennan et al., 2000) , soluble NRG1 induces the generation of satellite glia rather than Schwann cells in multipotent neural crest cells (Hagedorn et al., 2000) . In this study, we demonstrate that membrane-associated NRG1 type III, in contrast to soluble NRG1 isoforms, has the potential to induce the Schwann cell markers Oct-6 and S100 in cultures of multipotent neural crest-derived progenitors. Since cell death is minimal in the conditions chosen (Hagedorn et al., 1999) , our data identify locally presented NRG1 type III as an active Schwann cell differentiation signal.
Role of NRG1 Isoforms in Survival of Peripheral Progenitor Cells
In previous reports, variants of the type I isoform have been used to demonstrate the survival-promoting activity of NRG1 on Schwann cell precursors (Dong et al., 1995 (Dong et al., , 1999 . However, the late and restricted expression of NRG1 type I in the peripheral nervous system (PNS) makes this isoform unlikely to be involved in early Schwann cell development in vivo (Meyer et al., 1997) . Given their strong expression in sensory and motor neurons and based on in vivo functional analysis, NRG1 type II and, in particular, type III might be crucial for the early development of the Schwann cell lineage (Ho et al., 1995; Meyer et al., 1997; Wolpowitz et al., 2000) . Schwann cell precursors are absent in mutants in which signaling by both of these NRG1 forms is affected, whereas Schwann cell precursors are found along peripheral nerves in mutants lacking either type II or type III isoform (Meyer et al., 1997; Morris et al., 1999; Riethmacher et al., 1997; Woldeyesus et al., 1999; Wolpowitz et al., 2000) . Thus, type II and type III isoforms might compensate each other to regulate the earliest steps in Schwann cell precursor generation. Depletion of Schwann cell precursors in NRG1 mutants might be due to cell death of neural crest-derived progenitors. The survival of at least some multipotent progenitors is supported by NRG1 signaling (Paratore et al., 2001) , and, as we show here, both NRG1 type II and type III are able to promote survival of Schwann cell precursors in vitro. In addition, a role of NRG1 isoforms in regulating progenitor migration into peripheral nerves is conceivable (Britsch et al., 1998; Morris et al., 1999) .
Survival at a somewhat later stage in development, during the transition from a Schwann cell precursor to an early Schwann cell, is likely controlled by NRG1 type III. In mice carrying a type III-specific mutation, Schwann cell precursors initially form along peripheral nerves but are then progressively lost (Wolpowitz et al., 2000) . Our results indicate that soluble NRG1 type III is able to support survival of Schwann cell precursors, although less efficiently than other NRG1 isoforms (Dong et al., 1995 (Dong et al., , 1999 Brennan et al., 2000) . Thus, it is likely that NRG1 type III acts in combination with factors such as FGF2, PDGF-BB, and NT-3 to promote survival of Schwann cell precursors (Dong et al., 1995 (Dong et al., , 1999 Lobsiger et al., 2000) . Moreover, the retention of NRG1 type III at the cell surface (Schroering and Carey, 1998; Wang et al., 2001 ) might increase its anti-apoptotic activity. According to this model, neuronderived NRG1 signaling would support only those Schwann cell precursors that directly contact the axon. Such a mechanism, in concert with mitotic stimuli, would ensure a tight control of the Schwann cell number to be produced along the nerve.
Isoform-Specific Activities of NRG1 in Schwann Cell Differentiation
In cultures of Schwann cell precursors isolated from sciatic nerve, only about 54 -61% of the surviving cells displayed upregulated expression of Schwann cell differentiation markers after treatment with soluble NRG1 type II or type III. This number is lower than the differentiation rate observed by other authors, who used various soluble NRG1 type I forms or an isolated EGF domain of NRG1 (Dong et al., 1995 (Dong et al., , 1999 Brennan et al., 2000) . The discrepancy might be due to different NRG1 variants used or to subtle differences in culture conditions. Moreover, maturation of only a subpopulation of Schwann cell precursors might reflect heterogeneity of the cells. In any case, our data suggest that survival per se is not sufficient for full differentiation of Schwann cell precursors. Rather, differentiation might have to be actively promoted independently of survival. This is also supported by the recent report that endothelins act as survival factors of Schwann cell precursors while delaying their differentiation (Brennan et al., 2000) . Apparently, secreted NRG1 type II and III isoforms do not represent efficient Schwann cell differentiation factors. This is particularly evident in multipotent progenitors isolated from early DRG. With these cells, formation of Schwann cells was not stimulated by soluble NRG1 isoforms, even when added well above saturation. In contrast, forced cellular expression of NRG1 type III specifically induced Schwann cell traits in adjacent cells, demonstrating that local presentation of NRG1 is required to reveal its direct involvement in Schwann cell differentiation. In agreement with a role of membrane-bound, axon-derived NRG1 type III in regulating Schwann cell features, axonSchwann cell interactions have been shown to upregulate the expression of Oct-6 in Schwann cells (Scherer et al., 1994) . As mentioned above, soluble NRG1 type II regulates a satellite glial fate rather than Schwann cell development in DRG-derived multipotent progenitors (Hagedorn et al., 2000) . Intriguingly, simultaneous exposure of multipotent progenitors to NRG1 type II and membrane-bound NRG1 type III did not block the Schwann cell promoting activity of the type III isoform (data not shown), suggesting that axon-mediated NRG1 signaling is dominant over signaling by secreted NRG1.
Analysis of mutant mice revealed an important function of the transcription factor Oct-6 in Schwann cell myelination (Bermingham et al., 1996; Jaegle et al., 1996) . Previously, it has been shown that expression of Oct-6 in Schwann cells is regulated by the adenylyl cyclase-protein kinase A (PKA) pathway (Monuki et al., 1989) , and neural crest-derived multipotent progenitors upregulate Oct-6 expression upon treatment with the adenylate cyclase activator forskolin (Hagedorn et al., 2000) . Moreover, it has been proposed that the PKA pathway synergizes with NRG1 signaling to stimulate Oct-6 expression (Mandemakers et al., 2000) . It is noteworthy, therefore, that in multipotent progenitor cells, profound upregulation of Oct-6 expression by locally presented NRG1 type III occurred in the absence of exogenously added forskolin. Membrane-bound NRG1 may mimic the PKA pathway by activating similar target proteins. In support of this hypothesis, crosstalk between NRG1-and PKA-signal transduction pathways occurs and likely activates CREB (cAMP response element-binding protein) as a common downstream effector in cultures of postnatal Schwann cells (Kim et al., 1997; Tabernero et al., 1998) .
Our findings that membrane-bound NRG1 type III as opposed to soluble NRG1 isoforms is able to induce Oct-6 and S100 in multipotent neural crest-derived progenitors raise the question of how the specific activities of NRG1 signaling are brought about. NRG1 signaling can be affected by varying ErbB receptor combinations (reviewed in Buon-anno and Fischbach, 2001; Burden and Yarden, 1997) . In the developing PNS, this is an unlikely mechanism to control differential NRG1 signaling since the receptor heterodimer of ErbB2 and ErbB3 appears to be responsible for NRG1 signaling in all neural crest-derived glia at different stages (Grinspan et al., 1996; Levi et al., 1995; Shah et al., 1994; Vartanian et al., 1997) . Moreover, similar to soluble NRG1 isoforms, membrane-bound NRG1 type III stimulates phosphorylation of ErbB2 and ErbB3 receptors (Ho et al., 1995; Schroering and Carey, 1998) . It is conceivable, however, that a given ErbB receptor combination can discriminate among signaling by different forms of NRG1. Different NRG gene products can elicit differential usage of ErbB phosphorylation sites or recruit different signaling proteins to activated receptors, thereby stimulating distinct signaling pathways (Pinkas-Kramarski et al., 1998; Sweeney et al., 2000 Sweeney et al., , 2001 . Membrane association of NRG1 type III is mediated by a hydrophobic domain in its N terminus, 
FIG. 5.
Oct-6-and S100-positive Schwann cells associate with cells expressing membrane-bound myc-tagged NRG1 type III. Cells dissociated from E15 rat DRG were plated at high density onto fibronectin-coated plates and cultured over a period of 3-4 h. In order to remove neurons from the plate, the cultures were rinsed with cold PBS. Subsequently, cells were replated onto pDL/fibronectin-coated plates at high density and were infected with retrovirus expressing mycNRG1-III or with control retrovirus. Cultures were fixed after 4 days and stained for the tagged fusion protein using anti-Myc antibody visualized by Cy3-conjugated secondary antibody (A, C, E, and G). Anti-Oct-6 or anti-S100 antibody followed by a secondary antibody conjugated to FITC were used to reveal the presence of Schwann cells in the cultures. Nonneuronal cells in close vicinity to mycNRG1-III expressing clusters (as monitored by anti-Myc immunoreactivity, arrows) were found to express the Schwann cell markers S100 (C, D) or Oct-6 (G, H). Association of control-infected cells with Schwann cells was found with a significantly lower frequency (see Fig. 7 ). Phase-contrast (B, D, F, and H) . Magnification, ϫ40.
resulting in exposure of the C-terminal end of the ectodomain to the extracellular environment (Schroering and Carey, 1998) . Thus, the specific orientation of the NRG1 type III signaling domain might affect signal interpretation by the signal-receiving cell. In addition, cofactors such as PDZ-containing proteins or the transmembrane protein CD44 that interact with ErbB receptors might modulate NRG1 signaling (Garcia et al., 2000; Sherman et al., 2000) . Such mechanisms might also underlie the differential pathway usage observed in postnatal Schwann cell motility, survival, proliferation, and myelination (Li et al., 2001; Maurel and Salzer, 2000; Meintanis et al., 2001) .
Stage-Specific Responses of the Peripheral Glial Lineage to NRG1 Signaling
The multiple biological responses of neural crest derivatives to NRG signaling are not only triggered by the differential activities of NRG forms. Rather, the competence of a neural crest cell to interpret a given NRG signal apparently changes with time. NRG1 type II regulates expression of the satellite glia marker Erm in multipotent neural crest stem cells and DRG-derived progenitors, but once such cells have populated peripheral nerves as Schwann cell precursors, NRG1 type II is able to support survival rather than Erm expression (Hagedorn et al., 2000;  this study). As mentioned above, signaling by membranebound NRG1 type III appears to be dominant over NRG1 type II signaling, consistent with the idea that the exposure of a cell to axon-mediated NRG1 type III alters its intrinsic program and its capacity to interpret signaling by soluble NRG1. Thereby, priming by NRG1 type III signaling might be irreversible since a transition of an Erm-positive multipotent progenitor to a Schwann cell precursor but never of a Schwann cell precursor to an Erm-expressing cell has been observed (Hagedorn et al., 2000) . Based on our data, we conclude that continuous exposure to axon-derived, membrane-bound NRG1 type III would then allow Schwann cell precursors to survive and to differentiate into Schwann cells.
FIG. 7.
Membrane-bound NRG1 type III promotes Schwann cell differentiation. NRG1 type III-induced upregulation of Schwann cell markers was quantified. Association of S100-or Oct-6-positive cells with infected cells was scored when at least one Schwann cell was found in contact with an infected cell (determined by means of phase-contrast microscopy). Relative numbers are given in percentage of infected cells associated with Schwann cells. Each bar represents the mean (ϮSD) of three independent experiments. Between 100 and 120 infected cohorts were scored per experiment and condition. Scores were significantly different between NRG1 type III-expressing cells and control-infected cells for both S100 (Student's t test, P Ͻ 0.01) and Oct-6 expression (Student's t test, P Ͻ 0.03).
